GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals
European approval of Pembrolizumab for resected Stage III melanoma – KN-54 excerpts
2018-12-21
Trials & Approvals Autoimmune
Novartis’s Ligelizumab Progresses to Phase III Trial
2018-12-17
Trials & Approvals Alanine Aminotransferase
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
Trials & Approvals Hepatocellular Carcinoma
New hepatocellular carcinoma approval for Pembrolizumab – KN-224
2018-11-14
Trials & Approvals Multiple Myeloma
Empliciti®(elotuzumab) combination – New IO approval for relapsed Multiple Myeloma
2018-11-09
Trials & Approvals Immunotherapy Drug
Next Gen IO update – early phase clinical trials of anti-TIGIT/LAG3 antibodies
2018-11-08
Trials & Approvals Lung Cancer
Pembrolizumab Upstages Topline PD-1/L1 drugs in lung cancer tussle
2018-11-06
Trials & Approvals Breast Cancer
Pfizer’s Talzenna approved for breast cancer treatment
2018-10-25
Trials & Approvals
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
Trials & Approvals Anti-PD-1
Innovent reports clinical trial results of its anti-PD-1 monoclonal antibody
2018-09-26
Technology Inflammatory
Watching Biosimilar Entrants Alongside Blockbuster Patent Expiry Countdown
2018-09-25
Trials & Approvals Migraine
AJOVY™, Teva’s new migraine drug gets USFDA approval
2018-09-21
Trials & Approvals
Singapore HSA approves phase I/II clinical trial for precision T-cell receptor immunotherapy
2018-09-14
Trials & Approvals HIV
US FDA Allows Phase II Clinical Trials for China’s anti-HIV Two-Drug Combo Therapy
2018-09-07
Trials & Approvals Hemophilia A
Emicizumab promises weekly/biweekly prophylaxis in hemophilia-A patients
2018-09-04
1 … 47 48 49 50
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top